List of works - Morten Lamberts

Accuracy of the ICD-10 discharge diagnosis for syncope

scientific article published on 4 November 2012

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

scholarly article by Morten Lamberts et al published 15 April 2014 in Circulation

Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation

scientific article published on June 2017

Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study

scientific article published on 30 April 2014

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

scientific article

Atrial fibrillation and risk of stroke: a nationwide cohort study

scientific article

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

scientific article

CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer

scientific article published on 27 February 2018

Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.

scientific article published on 13 September 2013

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

scientific article

Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis

scientific article published on 04 January 2019

Dosage of angiotensin-II receptor blockers in heart failure patients following changes in Danish drug reimbursement policies

scientific article published on 24 June 2014

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

scientific article

Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study

scientific article

Incidence and influence of hospitalization for recurrent syncope and its effect on short- and long-term all-cause and cardiovascular mortality

scientific article published on 2 March 2014

Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study

scientific article published on 10 January 2017

Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study

scientific article published on 22 July 2014

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study

scientific article published on 14 October 2016

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction

scholarly article by Anne-Marie Schjerning Olsen et al published 16 October 2012 in Circulation

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

scientific article published on 14 February 2017

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

scientific article published on December 2014

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

scientific article

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

scientific article published on 11 August 2016

Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study

scientific article published on 2 January 2013

Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

scientific article published on 7 June 2013

Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study

scientific article published on 14 October 2014

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

scientific article published on 12 December 2012

Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study

scientific article published in November 2014

Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?

scientific article published on 5 February 2014

Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

scientific article

Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study

scientific article published on 18 November 2017

Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study

scientific article published on 9 August 2016

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups

scientific article published on 16 June 2014

Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study

scientific article published on 19 May 2015

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study.

scientific article

Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation

scientific article

Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings

scientific article

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study

scientific article

The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation

scientific article published on 01 April 2019

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

scientific article published on 15 May 2012

Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study

scientific article

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis

scientific article published on 12 October 2013

Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.

scientific article published on 17 February 2012

Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation

scientific article published in November 2017

List of works by Morten Lamberts

Accuracy of the ICD-10 discharge diagnosis for syncope

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation

Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

Atrial fibrillation and risk of stroke: a nationwide cohort study

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer

Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis

Dosage of angiotensin-II receptor blockers in heart failure patients following changes in Danish drug reimbursement policies

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study

Incidence and influence of hospitalization for recurrent syncope and its effect on short- and long-term all-cause and cardiovascular mortality

Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study

Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort study

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction

Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study

Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study

Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?

Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study

Return to the Workforce After First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups

Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study.

Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation

Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study

The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis

Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.

Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation